Canada Pension Plan Investment Board’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-81,500	Closed	-$6.13M	–	1339
2022 Q2	$6.13M	Buy	+81,500	New	+$3.62M	0.01%	501

Canada Pension Plan Investment Board's TPTX Position: Q3 2022 in Review

Canada Pension Plan Investment Board sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 81,500 shares — an estimated $6.13M sold.

Canada Pension Plan Investment Board first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $6.13M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Canada Pension Plan Investment Board reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Canada Pension Plan Investment Board sold 81,500 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $6.13M.
Canada Pension Plan Investment Board first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Canada Pension Plan Investment Board's Turning Point Therapeutics, Inc. Common Stock position peaked at $6.13M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2022, filed 14 Nov 2022.